Kevin Dai is a Managing Director at Vivo Capital. He has a background in clinical oncology pharmacy and equity research.

What Kevin can write

Writes checks ofNot reported
Comes in atSeries A, Series BMostly follows a lead
Email the firm[email protected]The firm's own inbox for founders.

Career

  1. Merck & Co.
  2. Memorial Sloan Kettering Cancer Center · Clinical Oncology Pharmacy Specialist
  3. Canaccord Genuity · equity research associate
  4. Vivo Capital · Managing Director
    Now

Focus

healthcarelife sciencesbiotechnologyspecialty pharmaceutical

Education

Ernest Mario School of Pharmacy at Rutgers, Pharm.DUniversity of Chicago Medical Center, internal medicine residencyMemorial Sloan Kettering Cancer center, oncology residency

Also at Vivo Capital

Partners like Kevin

At firms with a similar stage, sector and check size.

Alert me when Vivo Capital is active

One email when Kevin's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Kevin Dai?

Kevin Dai is a Managing Director at Vivo Capital. He has a background in clinical oncology pharmacy and equity research.

How much does Kevin Dai invest?

Vivo Capital has not reported a check size. It invests at series a, series b.

How do I pitch Kevin Dai?

Email [email protected], the firm's inbox for founders, and name Kevin in the subject. A warm intro from a founder Vivo Capital backed works better.

What did Kevin Dai do before Vivo Capital?

Merck & Co.; Clinical Oncology Pharmacy Specialist at Memorial Sloan Kettering Cancer Center; equity research associate at Canaccord Genuity.

Last updated 2026-10-15. Is this you? Ask for a correction.